Dr Fanny Franchini (PRIMCAT Chief Investigator A) will share information about the PRIMCAT program and how it supports HTA processes in Australia.
Professor Grant McArthur and Dr Jennifer Soon (PRIMCAT Clinical Research Fellow) will share methodology and results of the PRIMCAT Horizon Scanning program. This includes sharing the Top 5 Cancer Treatments most likely to be presented for regulatory approval in the next 5 years for nominated cancer tumour streams.
For more information about the HTA Review and the Horizon Scanning Forum, visit Medicines Australia.